U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: November 6-12, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: November 6-12, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 11/09/2022
Location: Virtual
Subject: FDA Public Workshop; Bridging Drug Efficacy and Safety to the Obese: Considerations and Scientific Approaches
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, media, and other registered attendees

Event Date: 11/10/2022
Location: Virtual
Subject: Food Safety Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Safe Food Coalition

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 11/09/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several GS1 US, Inc. staff and their Board of Governors

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 11/07/2022
Location: Virtual
Subject: Association for Accessible Medicines (AAM) GRx+Biosims Conference; Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, media, and other stakeholders

Event Date: 11/10/2022
Location: Virtual
Subject: Final Update on Precision Medicine in Acute Respiratory Distress Syndrome (ARDS)
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of University of California San Francisco (UCSF) Breast Care Center

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 11/08/2022
Location: Baltimore, MD
Subject: Johns Hopkins University School of Medicine Lecture
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Johns Hopkins University School of Medicine Lecture

Event Date: 11/08/2022
Location: Virtual
Subject: NIH/National Institute of Allergy and Infectious Diseases Meeting; Regulatory and Policy Considerations
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of NIH/National Institute of Allergy and Infectious Diseases Meeting

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 11/10/2022
Location: Virtual
Subject: Utah BioHive Summit; CDRH Town Hall
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, researchers, media, and other stakeholders

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 11/08/2022
Location: Washington, DC
Subject: Truth Initiative Impact Series; A Conversation with FDA’s Center for Tobacco Products Director, Dr. Brian King, and Truth Initiative CEO and President, Robin Koval
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from Truth Initiative

Event Date: 11/08/2022
Location: Virtual
Subject: Update on FDA's Tobacco Regulation
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from the office of Representative Nancy Pelosi (D-CA)

Event Date: 11/09/2022
Location: Virtual
Subject: Listening Session; Juul Labs, Inc.
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from Juul Labs, Inc.

Event Date: 11/09/2022
Location: Virtual
Subject: Tobacco Free Portfolios Introductory Meeting
FDA Participant/Group: KARIN RUDOLPH;
Non FDA Participant/Group: Bronwyn King, Lisa Nicolaou, Rebecca Brown (Tobacco Free Portfolios);

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

Back to Top